Aarti Drugs Limited (AARTIDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.104x

Based on the latest financial reports, Aarti Drugs Limited (AARTIDRUGS) has a cash flow conversion efficiency ratio of 0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.52 Billion ≈ $16.48 Million USD) by net assets (Rs14.69 Billion ≈ $158.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AARTIDRUGS net asset quality index to measure how much of total assets are equity-financed.

Aarti Drugs Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aarti Drugs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Aarti Drugs Limited (AARTIDRUGS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Aarti Drugs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarti Drugs Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
VST Industries Limited NSE:VSTIND	0.048x
Bank7 Corp NASDAQ:BSVN	0.064x
Shanghai Ailu Package Co. Ltd. SHE:301062	N/A
Nawi Brothers Group Ltd TA:NAWI	-0.714x
EGing Photovoltaic Technology Co Ltd SHG:600537	-0.199x
Kuo Toong International Co Ltd TWO:8936	0.027x
Ophir High Conviction Fund AU:OPH	-0.029x
CIMB Thai Bank Public Company Limited BK:CIMBT	-0.088x

Annual Cash Flow Conversion Efficiency for Aarti Drugs Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aarti Drugs Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Aarti Drugs Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs13.69 Billion ≈ $148.09 Million	Rs2.45 Billion ≈ $26.45 Million	0.179x	-36.21%
2024-03-31	Rs12.82 Billion ≈ $138.64 Million	Rs3.59 Billion ≈ $38.82 Million	0.280x	+148.83%
2023-03-31	Rs11.93 Billion ≈ $128.98 Million	Rs1.34 Billion ≈ $14.51 Million	0.113x	+67.45%
2022-03-31	Rs10.36 Billion ≈ $112.07 Million	Rs696.36 Million ≈ $7.53 Million	0.067x	-60.36%
2021-03-31	Rs9.13 Billion ≈ $98.78 Million	Rs1.55 Billion ≈ $16.75 Million	0.170x	-55.88%
2020-03-31	Rs6.52 Billion ≈ $70.56 Million	Rs2.51 Billion ≈ $27.12 Million	0.384x	+45.95%
2019-03-31	Rs5.43 Billion ≈ $58.77 Million	Rs1.43 Billion ≈ $15.47 Million	0.263x	+71.88%
2018-03-31	Rs4.55 Billion ≈ $49.25 Million	Rs697.66 Million ≈ $7.54 Million	0.153x	-63.96%
2017-03-31	Rs4.11 Billion ≈ $44.42 Million	Rs1.75 Billion ≈ $18.88 Million	0.425x	+13.96%
2016-03-31	Rs3.57 Billion ≈ $38.65 Million	Rs1.33 Billion ≈ $14.42 Million	0.373x	+9.88%
2015-03-31	Rs3.08 Billion ≈ $33.33 Million	Rs1.05 Billion ≈ $11.31 Million	0.339x	-10.76%
2014-03-31	Rs2.51 Billion ≈ $27.13 Million	Rs954.26 Million ≈ $10.32 Million	0.380x	+6.26%
2013-03-31	Rs2.08 Billion ≈ $22.45 Million	Rs743.10 Million ≈ $8.04 Million	0.358x	+72.40%
2012-03-31	Rs1.76 Billion ≈ $19.09 Million	Rs366.41 Million ≈ $3.96 Million	0.208x	+64.76%
2011-03-31	Rs1.63 Billion ≈ $17.65 Million	Rs205.60 Million ≈ $2.22 Million	0.126x	-68.79%
2010-03-31	Rs1.46 Billion ≈ $15.84 Million	Rs591.20 Million ≈ $6.39 Million	0.404x	-18.58%
2009-03-31	Rs1.23 Billion ≈ $13.35 Million	Rs612.10 Million ≈ $6.62 Million	0.496x	+94.81%
2008-03-31	Rs1.12 Billion ≈ $12.06 Million	Rs283.87 Million ≈ $3.07 Million	0.255x	-12.94%
2007-03-31	Rs1.00 Billion ≈ $10.83 Million	Rs292.69 Million ≈ $3.17 Million	0.292x	--

About Aarti Drugs Limited

NSE:AARTIDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$401.98 Million

Rs37.17 Billion INR

Market Cap Rank

#13287 Global

#684 in India

Share Price

Rs407.25

Change (1 day)

-3.67%

52-Week Range

Rs319.75 - Rs525.35

All Time High

Rs1001.57